echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Production Process of Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)

    The Production Process of Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)

    • Last Update: 2023-04-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The production process of Atomoxetine Related Compound C (10 mg) (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride) involves a series of chemical reactions and steps that convert raw materials into the final product.
    In the chemical industry, the production process is a critical factor in ensuring the quality and consistency of the final product.
    The following is a detailed overview of the production process of Atomoxetine Related Compound C (10 mg).


    Step 1: Preparation of the starting material
    The production process of Atomoxetine Related Compound C (10 mg) begins with the preparation of the starting material.
    The starting material in this case is a mixture of N-methyl-3-phenyl-3-(p-tolyl)propanamine and hydrochloric acid.
    This mixture is a solid that is used as the starting material for the subsequent reactions.


    Step 2: Condensation reaction
    The next step in the production process of Atomoxetine Related Compound C (10 mg) is a condensation reaction.
    In this reaction, the N-methyl-3-phenyl-3-(p-tolyl)propanamine is reacted with hydrochloric acid to form N-methyl-3-phenyl-3-(p-tolyl)propan-1-amine.
    This reaction is carried out in the presence of a solvent such as dichloromethane.


    Step 3: Hydrolysis
    The next step in the production process of Atomoxetine Related Compound C (10 mg) is hydrolysis.
    In this step, the N-methyl-3-phenyl-3-(p-tolyl)propan-1-amine is treated with water to form N-methyl-3-phenyl-3-(p-tolyl)propan-1-amine hydrochloride.
    This reaction is carried out in the presence of a solvent such as ethanol.


    Step 4: Purification
    The final step in the production process of Atomoxetine Related Compound C (10 mg) is purification.
    In this step, the N-methyl-3-phenyl-3-(p-tolyl)propan-1-amine hydrochloride is purified to remove any impurities that may have been introduced during the previous steps.
    This is typically done by using a solvent such as ethyl acetate to extract the impurities and then evaporating the solvent to leave a pure sample of Atomoxetine Related Compound C (10 mg).


    Overall, the production process of Atomoxetine Related Compound C (10 mg) involves a series of chemical reactions and steps that convert the raw material into the final product.
    Each step in the process is carefully designed and executed to ensure the quality and consistency of the final product.
    The end result is a high-quality, pure sample of Atomoxetine Related Compound C (10 mg) that is used in a variety of applications in the pharmaceutical industry.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.